Provide statistical support for Phase I–IV clinical trials.
Participate in protocol development, study design, and sample size calculations.
Prepare and review Statistical Analysis Plans (SAPs), TLF shells, and randomization specifications.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. They have over 4,000 professionals in more than 20 countries with a mission to contribute to a healthier and safer world.
Represent the Biostatistics function for complex studies or at project level.
Independently contribute to design of early/late-stage protocols across multiple therapeutic areas and help draft protocols or amendments.
Develop and write statistical analysis plans and perform statistical analyses for interim and final reports to be submitted to regulatory agencies.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. They have over 4,000 professionals in more than 20 countries across the Americas, Europe, and Asia-Pacific.
Contribute to the design of early/late-stage protocols across multiple therapeutic areas.
Develop and write statistical analysis plans, and perform statistical analyses for interim and final reports.
Support submission activities, including design, analysis and reporting of integrated summaries for safety and efficacy.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. With over 4,000 professionals in more than 20 countries, they focus on quality, professional development, and a supportive culture.
Define and execute the scientific vision and R&D roadmap aligned with company milestones.
Oversee lead preclinical programs in focus indications, such as tRNA elevation in neuromuscular diseases.
Drive IND-enabling studies, including biodistribution, toxicology, and dose-finding.
XtRNA Bio is a pioneering biotechnology company developing a proprietary tRNA therapeutic platform for underserved patients with rare genetic diseases and high unmet medical needs. They are advancing a novel approach to correct translational defects at their root, from discovery through to the clinic — with a focus on meaningful, durable benefit for patients who currently have no options.
Provide strategic leadership for biometrics across all clinical development programs.
Define and implement an integrated biometrics strategy supporting clinical trial design and data quality.
Lead and oversee CROs and external vendors responsible for biostatistics statistical programming and related biometrics activities.
Braveheart Bio is a Bay Area–based biopharmaceutical company pioneering best-in-class therapies for cardiovascular disease. With a proven leadership team and a strong financial foundation, they represent an outstanding opportunity for ambitious, mission-driven professionals.
Developed and executed study protocols, analysis plans, and study reports.
Designed and managed epidemiological, biomarker and/or data science projects.
Planned, designed, and conducted analyses for internal and external decision making.
Syneos Health is a fully-integrated life sciences services organization that accelerates customer success. They partner with innovators across the drug development and commercialization continuum, helping them navigate complexity and anticipate change. They have over 25,000 colleagues.
Develop client-ready deliverables such as study protocols, statistical analysis plans, and technical reports for health technology assessment submissions.
Manage project components by collaborating with team members to ensure timely delivery, financial performance, and high-quality outputs, while handling day-to-day client communications.
Provide mentorship and direction to junior researchers, contribute to business development proposals, and apply technical expertise in systematic reviews and indirect treatment comparisons like NMA and MAIC.
Precision Medicine Group is a global portfolio organization specializing in evidence synthesis for health technology assessments in the pharmaceutical industry. The company has a culture similar to a start-up, is well-funded, and prides itself on being a visionary leader in its field.
Enter clinical trial data into EDC systems accurately and on time per study protocols and sponsor requirements.
Perform routine data quality checks, identify and resolve discrepancies, and support query resolution to keep studies on track.
Track data entry timelines across multiple concurrent studies and support database lock activities with organized, audit-ready documentation.
Profound Research partners with community physicians to offer clinical trials as a therapeutic option for their patients, handling all infrastructure and operations. It is a collaborative organization that invests in professional growth and offers competitive benefits.
Serve as a scientific expert in due diligence efforts for external platforms, technologies and partnership opportunities.
Evaluate CAR T and gene delivery approaches, including vector systems, targeting strategies, and immune cell engineering methodologies.
Assess the scientific validity, differentiation, and translational potential of emerging technologies in the context of autoimmune disease.
Kyverna Therapeutics is a biotechnology company focused on developing CAR T and immune cell engineering therapies for autoimmune diseases. The company fosters a collaborative culture where scientific and business teams work together to evaluate innovative technologies.
Lead external pre-clinical research and partnerships with CROs and academia for functional validation of immuno-oncology therapies.
Direct immune functional assays and validate targets/biomarkers identified by AI/ML platforms using patient-derived samples.
Build scalable external research networks and develop a long-term roadmap to establish internal translational research capabilities.
Natera is a global leader in cell-free DNA testing, focused on oncology, women's health, and organ health to enable personalized diagnostics. The company employs a diverse team of professionals from world-class institutions who are dedicated to changing disease management.